GlassScriptPhysician profile
Maureen Ross
NPI 1366410979
$525.17
in general payments reported to CMS, 2019-2025
9 companies · $320 in 2025
The $320 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2022: $23.81 · 2023: $34.39 · 2024: $21.93 · 2025: $320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $376.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $376.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Beigene USA, INC. | $124.99 | 2021 | |
| Abbvie INC. | $123.21 | 2025 | |
| Novocure INC. | $111.68 | 2025 | Optune Gio |
| Glaxosmithkline, LLC. | $62.11 | 2025 | Ojjaara |
| Pharmacyclics LLC, An Abbvie Company | $34.39 | 2023 | Epkinly |
| Seagen INC. | $23.81 | 2022 | |
| Novartis Pharmaceuticals Corporation | $23.05 | 2025 | |
| Merck Sharp & Dohme LLC | $21.93 | 2024 | Lynparza |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maureen Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.